1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 57 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Associations between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with TamoxifenSchroth, W.; Goetz, M.; Hamann, U.; Fasching, P.; Schmidt, M.; Winter, S.; Fritz, P.; Simon, W.; Suman, V.; Ames, M.; Safgren, S.; Kuffel, M.; Ulmer, H.; Bolander, J.; Strick, R.; Beckmann, M.; Koelbl, H.; Weinshilboum, R.; Ingle, J.; Eichelbaum, M.; et al.
2013European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013Baccarani, M.; Deininger, M.; Rosti, G.; Hochhaus, A.; Soverini, S.; Apperley, J.; Cervantes, F.; Clark, R.; Cortes, J.; Guilhot, F.; Hansen-Hjorth, H.; Hughes, T.; Kantarjian, H.; Kim, D.; Larson, R.; Lipton, J.; Mahon, F.; Martinelli, G.; Mayer, J.; Muller, M.; et al.
2022Thrombectomy vs Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International CohortSarraj, A.; Albers, G.W.; Blasco, J.; Arenillas, J.F.; Ribo, M.; Hassan, A.E.; Pérez de la Ossa, N.; Wu, T.Y.-H.; Cardona Portela, P.; Abraham, M.G.; Chen, M.; Maali, L.; Kleinig, T.J.; Cordato, D.; Wallace, A.N.; Schaafsma, J.D.; Sangha, N.; Gibson, D.P.; Blackburn, S.L.; De Lera Alfonso, M.; et al.
2019Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaBell, C.C.; Fennell, K.A.; Chan, Y.C.; Rambow, F.; Yeung, M.M.; Vassiliadis, D.; Lara, L.; Yeh, P.; Martelotto, L.G.; Rogiers, A.; Kremer, B.E.; Barbash, O.; Mohammad, H.P.; Johanson, T.M.; Burr, M.L.; Dhar, A.; Karpinich, N.; Tian, L.; Tyler, D.S.; MacPherson, L.; et al.
2019Recommendations for core outcome domain set for Whiplash-Associated Disorders (CATWAD)Chen, K.; Andersen, T.; Carroll, L.; Connelly, L.; Côté, P.; Curatolo, M.; Elliott, J.; Grant, G.; Jull, G.; Kasch, H.; MacDermid, J.; Malmström, E.-M.; Maujean, A.; McLean, S.A.; Nielsen, M.; Rebbeck, T.; Söderlund, A.; Sterling, J.; Treleaven, J.; Walton, D.M.; et al.
2012Death adder envenoming causes neurotoxicity not reversed by antivenom - Australian snakebite project (ASP-16)Johnston, C.; O'Leary, M.; Brown, S.; Currie, B.; Halkidis, L.; Whitaker, R.; Close, B.; Isbister, G.; Nagree, Y.; Ker, F.; Greene, S.; Taylor, M.; Macrokanis, C.; Wilke, G.; Coulson, A.; Barnes, C.; Bonni, R.; Whitake, R.; Halkidis, L.; Isbiste, G.; et al.; de Silva, J.
2015A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinomaPal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2008Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialDavis, S.; Donnan, G.; Parsons, M.; Levi, C.; Butcher, K.; Peeters, A.; Barber, P.; Bladin, C.; De Silva, D.; Byrnes, G.; Chalk, J.; Fink, J.; Kimber, T.; Schultz, D.; Hand, P.; Frayne, J.; Hankey, G.; Muir, K.; Gerraty, R.; Tress, B.; et al.
2011Apixaban versus Warfarin in patients with atrial fibrillationGranger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al.

Discover